Semaglutide food noise: what changes
Semaglutide produces meaningful but slightly less dramatic food noise reduction than tirzepatide. The mechanism is GLP-1 receptor activation in reward-processing brain regions.
The mechanism
Same mechanism as tirzepatide on the GLP-1 side. Semaglutide doesn't have the GIP arm, which means slightly less appetite-related signaling overall. Most patients report substantial food noise reduction; the magnitude is comparable to tirzepatide for most patients but the dual-mechanism advantage of tirzepatide is real for a subset.
What to expect
Most patients describe food noise reduction within 2-4 weeks (slightly slower than tirzepatide because of the slower dose ramp). Reduction is dose-dependent: 1mg semaglutide produces less reduction than 2.4mg semaglutide. Some patients hit complete silence; some describe quieter version of normal; some describe minimal change.
Management
Nothing to manage if it's working as expected. Watch for the muted-reward pattern (anhedonia beyond food) which is less common than on tirzepatide but possible. If food noise reduction is partial and weight loss is suboptimal, escalating to the higher semaglutide dose (2.4mg Wegovy) often increases the reduction.
When to escalate
Anhedonia lasting more than 2-3 weeks. New-onset depression. Suicidal ideation (rare but possible; warrants immediate stop and mental health evaluation).
- STEP-1 (Wilding et al., NEJM 2021)
- EMA review of GLP-1 mental health (2024)